Alternatives to Rhythm Pharmaceuticals

Global healthcare company focused on diabetes care, obesity, and rare blood disorders.

A biotechnology company developing genetic therapies for rare disorders.

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Global pharmaceutical company focused on developing and manufacturing medicines.

A global pharmaceutical and biotechnology corporation developing innovative medicines and vaccines for various therapeutic areas.

OMGene is a biotechnology company focused on developing gene therapies for rare genetic diseases.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing treatments for rare inherited diseases.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Lutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Developing engineered biologics to harness the immune system for disease treatment.